AstraZeneca PLC (AZN) Stock Forecast
Data as of Jul 31, 2026Healthcare · Current price $170.41 (-0.49%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jul 9, 2025 | Luisa Hector | Berenberg Bank | $194.00 | +13.8% |
| Nov 13, 2024 | Etzer Darout | BMO Capital | $176.00 | +3.3% |
| Sep 11, 2024 | Etzer Darout | BMO Capital | $178.00 | +4.5% |
| May 30, 2024 | John Eade | Argus Research | $170.00 | -0.2% |
| May 28, 2024 | Etzer Darout | BMO Capital | $164.00 | -3.8% |
| Jul 12, 2023 | Andrew Berens | Leerink Partners | $158.00 | -7.3% |
Top Analysts Covering AZN
AZN vs Sector & Market
| Metric | AZN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.25 | 2.42 |
| Analyst Count | — | 8 | 19 |
| Target Upside | +10.4% | +16366.1% | +18.0% |
| P/E Ratio | 25.66 | 2.99 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $15.78B | $16.10B | $16.33B | 4 |
| 2026-12-31 | $16.38B | $16.72B | $16.96B | 4 |
| 2027-03-31 | $15.24B | $15.55B | $15.77B | 4 |
| 2027-06-30 | $15.89B | $16.21B | $16.45B | 3 |
| 2027-09-30 | $16.87B | $17.21B | $17.46B | 3 |
| 2027-12-31 | $17.28B | $17.64B | $17.89B | 3 |
| 2028-12-31 | $71.78B | $71.91B | $72.03B | 18 |
| 2029-12-31 | $74.14B | $77.72B | $79.80B | 11 |
| 2030-12-31 | $79.01B | $82.82B | $85.04B | 9 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $2.62 | $2.69 | $2.74 | 1 |
| 2026-12-31 | $2.46 | $2.53 | $2.58 | 1 |
| 2027-03-31 | $2.78 | $2.85 | $2.90 | 1 |
| 2027-06-30 | $2.74 | $2.81 | $2.86 | 1 |
| 2027-09-30 | $3.05 | $3.13 | $3.19 | 1 |
| 2027-12-31 | $2.64 | $2.71 | $2.76 | 1 |
| 2028-12-31 | $9.68 | $12.90 | $14.35 | 7 |
| 2029-12-31 | $13.75 | $14.63 | $15.14 | 2 |
| 2030-12-31 | $15.41 | $16.39 | $16.96 | 5 |
Frequently Asked Questions
What is the analyst consensus for AZN?
The consensus among 0 analysts covering AstraZeneca PLC (AZN) is — with an average price target of $186.67.
What is the highest price target for AZN?
The highest price target for AZN is $194.00, set by Luisa Hector at Berenberg Bank on 2025-07-09.
What is the lowest price target for AZN?
The lowest price target for AZN is $158.00, set by Andrew Berens at Leerink Partners on 2023-07-12.
How many analysts cover AZN?
0 analysts have issued ratings for AstraZeneca PLC in the past 12 months.
Is AZN a buy or sell right now?
Based on 0 analyst ratings, AZN has a consensus rating of — with a +10.4% upside to the consensus target of $186.67.
What are the earnings estimates for AZN?
Analysts estimate AZN will report EPS of $2.69 for the period ending 2026-09-30, with revenue estimated at $16.10B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.